Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Rat PTN ELISA Kit (AC2422)
Cat.#: ASET-1011
Specifications
Description Rat PTN ELISA Kit allows for the in vitro quantitative determination of rat PTN concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Rat Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 18.75 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 31.25-2000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1408 Horse Luteinizing Hormone ELISA Kit (AC2819) Quantitative inquiry ASET-2501 Human Ferritin Heavy Chain ELISA Kit (AC3912) Quantitative inquiry ASET-1586 Mouse GFAP ELISA Kit (AC2997) Quantitative inquiry ASET-1568 Human GPCR GPR35 ELISA Kit (AC2979) Quantitative inquiry ASET-2197 Human HSD17B1 ELISA Kit (AC3608) Quantitative inquiry ASET-2018 Rat beta MSH ELISA Kit (AC3429) Quantitative inquiry ASET-1615 Human SOX10 ELISA Kit (AC3026) Quantitative inquiry ASET-1266 Mouse Cathepsin D ELISA Kit (AC2677) Quantitative inquiry ASET-1634 Human Adenosine Receptor A2a ELISA Kit (AC3045) Quantitative inquiry ASET-2067 Rat GMFB ELISA Kit (AC3478) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket